Table 2.
The incidence of adverse reactions between the treatment group and control group.
| treatment group (n=1669) | control group (n=1664) | |
|---|---|---|
| blood pressure elevation | 24 (1.44%) | 38 (2.23%) |
| facial flushing | 22 (1.32%) | 30 (1.80%) |
| nausea and vomiting | 29 (1.74%) | 82 (4.93%) |
| abdominal discomfort | 5 (0.30%) | 7 (0.42%) |
| chest discomfort | 15 (0.90%) | 34 (2.04%) |
| arrhythmia | 11 (0.66%) | 20 (1.20%) |
| allergic reaction | 1 (0.06%) | 0 (0.00%) |